Effect and Mechanism of miR-26a-5p on Proliferation and Apoptosis of Hepatocellular Carcinoma Cells

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.28620797
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang D, Liu S, Li X, Hu W, Han C. KLF4 suppresses the migration of hepatocellular carcinoma by transcriptionally upregulating monoglyceride lipase. Am J Cancer Res. 2018;8(6):1019–1029.30034939
   PubMed Web of Science ®Google Scholar
• Jiang T, Guan LY, Ye YS, Liu HY, Li R. MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12. Am J Cancer Res. 2017;7(6):1310–1321.28670493
   PubMed Web of Science ®Google Scholar
• Tao J, Liu Z, Wang Y, et al. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Biomed Pharmacother. 2017;93:420–428. doi:10.1016/j.biopha.2017.06.07028666208
   PubMed Web of Science ®Google Scholar
• Ghanbari R, Mosakhani N, Asadi J, et al. Downregulation of plasma MiR-142-3p and miR-26a-5p in patients with colorectal carcinoma. Iran J Cancer Prev. 2015;8(3):e2329. doi:10.17795/ijcp26413249
   PubMedGoogle Scholar
• Shi D, Wang H, Ding M, et al. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma. Onco Targets Ther. 2019;12:6605–6616. doi:10.2147/OTT.S20599431496749
   PubMed Web of Science ®Google Scholar
• Wang H, Hu Z, Chen L. Enhanced plasma miR-26a-5p promotes the progression of bladder cancer via targeting PTEN. Oncol Lett. 2018;16(4):4223–4228. doi:10.3892/ol.2018.916330197668
   PubMed Web of Science ®Google Scholar
• Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem. 2008;283(48):33437–33446. doi:10.1074/jbc.M80201620018832382
   PubMed Web of Science ®Google Scholar
• Dong J, Wang R, Ren G, et al. HMGA2-FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer. Clin Cancer Res. 2017;23(13):3461–3473. doi:10.1158/1078-0432.CCR-16-218028119367
   PubMed Web of Science ®Google Scholar
• Zhao YC, Jiao Y, Li YQ, Fu Z, Yang ZY, He M. Elevated high mobility group A2 expression in liver cancer predicts poor patient survival. Rev Esp Enferm Dig. 2019;112.
   Web of Science ®Google Scholar
• Shi C, Zhang Z. MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1. Oncol Rep. 2017;37(1):501–509. doi:10.3892/or.2016.524227878258
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu X, Liu Z, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 2017;16(1):103. doi:10.1186/s12943-017-0675-y28606154
   PubMedGoogle Scholar
• Yuan J, Ji H, Xiao F, et al. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1. Biochem Biophys Res Commun. 2017;483(1):578–584. doi:10.1016/j.bbrc.2016.12.10227998770
   PubMed Web of Science ®Google Scholar
• Rizzo M, Berti G, Russo F, et al. Discovering the miR-26a-5p targetome in prostate cancer cells. J Cancer. 2017;8(14):2729–2739. doi:10.7150/jca.1839628928862
   PubMed Web of Science ®Google Scholar
• Song Q, Liu B, Li X, et al. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGbeta8- JAK2/STAT3 axis. Biochem Biophys Res Commun. 2018;501(2):494–500. doi:10.1016/j.bbrc.2018.05.02029746867
   PubMed Web of Science ®Google Scholar
• Bao H, Li X, Li H, et al. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. J Biosci. 2017;42(1):103–111. doi:10.1007/s12038-016-9662-528229969
   PubMed Web of Science ®Google Scholar
• Chang L, Li K, Guo T. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC. Clin Transl Oncol. 2017;19(6):695–703. doi:10.1007/s12094-016-1582-127864783
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137(6):1005–1017. doi:10.1016/j.cell.2009.04.02119524505
   PubMed Web of Science ®Google Scholar
• Liang R, Xiao G, Wang M, et al. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma. Biomed Pharmacother. 2018;107:1434–1446. doi:10.1016/j.biopha.2018.08.09930257360
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen F, Zhao M, et al. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186. J Biol Chem. 2017;292(37):15395–15407. doi:10.1074/jbc.M117.78373828765279
   PubMed Web of Science ®Google Scholar
• Sgarra R, Pegoraro S, Ros G, et al. High Mobility Group A (HMGA) proteins: molecular instigators of breast cancer onset and progression. Biochim Biophys Acta Rev Cancer. 2018;1869(2):216–229. doi:10.1016/j.bbcan.2018.03.00129518471
   PubMed Web of Science ®Google Scholar
• Gong J, Wang Y, Jiang B, Xu B, Hu C. Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer. Cancer Manag Res. 2019;11:4075–4084. doi:10.2147/CMAR.S19928931118815
   PubMed Web of Science ®Google Scholar
• Esmailzadeh S, Mansoori B, Mohammadi A, Shanehbandi D, Baradaran B. siRNA-mediated silencing of HMGA2 induces apoptosis and cell cycle arrest in human colorectal carcinoma. J Gastrointest Cancer. 2017;48(2):156–163. doi:10.1007/s12029-016-9871-z27629422
   PubMed Web of Science ®Google Scholar